V-Safe suggests the VAERS Under Reporting Factor (URF) averages over 60 for the many different adverse event symptoms

This implies previous deaths and injuries are 50% higher than rrior estimates (prior estimated URF was 40)

The great team at VaersAnalysis have done some excellent work on comparing the recently released V-Safe data from 10 million cell-phone contributors on their experiences with the C19 injections with the output from VAERS.

The bottom line = V-Safe data indicates a wide range of different URF’s for each type of adverse event, but indicates that the average URF across all symptoms is over SIXTY, compared to the likely URF of 41 using narrower symptom analysis compiled by Dr Jessica Rose from VAERS data here:

Determining the VAERS Under-Reporting Multiplier (healthimpactnews.com)

https://healthimpactnews.com/determining-the-vaers-under-reporting-multiplier/

Maybe the symptoms of each adverse event are signs of impending morbidities and serious injuries, maybe they aren’t. We don’t know BECAUSE THE C19 INJECTIONS ARE EXPERIMENTAL!

VaersAnalysis compiles data from the Vaccine Adverse Events Reporting System (VAERS) and presents it in a digestible form. It complements work done on a pioneering VAERS analysis site COVID Vaccine Data - OpenVAERS https://www.openvaers.com/covid-data

A word of caution: Top level VAERS displays data on ALL vaccines for ALL US companies administering vaccines GLOBALLY since the inception of VAERS – not just C19 injections data - from all over the world, not just the US.

OpenVaers and VaersAnalysis analyse, present the data and its granularity in slightly different ways. The VaersAnalysis team clearly present ONLY US data from ONLY US C19 injections.

Let’s dive in to the VaersAnalysis presentation of V-Safe data compared to VAERS.

Here is a link to the ICAN website that has (fought for and) extracted the V-Safe data that allows its reporting along multiple dimensions (hat tip to Messrs Bigtree and Siri).

ICAN v-safe Dashboard - ICAN - Informed Consent Action Network (icandecide.org)

https://www.icandecide.org/v-safe/

V-Safe data is self-reported, as is VAERS data. Around 2/3 to ¾ of VAERS data is completed (after about half an hour per report) by medical professionals that are more likely to report an accurate diagnosis. There have been 878,000 adverse events reports uploaded onto the VAERS system in the 21 months to 30 September 2022, including 14,700 deaths. There were almost 6.5 million reported health impacts reported by the 10 million V-Safe volunteers regularly “pinged” by the CDC over the full period that V-Safe was operating. Some health impacts were trivial. The VaersAnalysis team has attempted to strip out the more trivial reports.

V-Safe completion was by 10 million or so volunteers answering pre-determined questions within narrower data entry tabs than VAERS data entry. Voluntary free format text fields have been withheld by the CDC that would provide valuable granularity of injuries. In other words, the V-Safe respondents were volunteers BEFORE the injections, the VAERS reports are for those that sustained injuries AFTER the injections. Maybe the V-Safe volunteers are more likely to be participants in radio talk shows than VAERS sufferers, but that’s an awful lot of “activists”!

V-Safe itself wlll have an under-reporting factor, though probably it is far closer to full reporting than VAERS. Perhaps at least 80% of all adverse events were reported – but, for ease, we can assume ALL of such events were reported on cell phones to V-Safe.

Here is the direct comparison between V-Safe and VAERS with estimates of the varying URF’s of VAERS per symptom, using V-Safe data as a benchmark.

The geometric mean of the URF’s in the table has been calculated at 61, the mean at 92, the median at 66 – the range of URF’s is a wide 267 with a standard deviation of 75 (2/3 of all URF’s are within 75 of the mean of 92).

The above data table has been extracted from here:

Estimating the Under-Reporting Factor (URF) in VAERS by Way of the Recently Released V-Safe Data – VAERS Analysis

https://vaersanalysis.info/2022/10/08/estimating-the-under-reporting-factor-urf-in-vaers-by-way-of-the-recently-released-v-safe-data/

The data is not compared to a placebo, as would be the case during a clinical trial, so there is no adjustment for “background events”. Neither is VAERS data. The clinical trial data does show a comparison to a placebo. There were around THREE times the number of adverse events in the Pfizer clinical trial injected group than in the placebo group.

A major highlight is the almost 663,000 in the “Outpatient/Urgent Care Clinic + Telehealth/Virtual/Email Health Consultation”. A rate of 6.6% or over one in 16. More granularity needed to differentiate between zoom calls and trips to clinics!

A few extracts from the VaersAnalysis post:

“Here are the most notable overall highlights regarding the data:

7.7% of the V-Safe population needed medical care

25.4% of the V-Safe population either were unable to perform normal activities or missed work or school.

Women reported adverse events at rate of approximately 2.7 times the rate of men.”

The 25% figure can be loosely compared to the 26% rate of adverse events from the Pfizer clinical trial on page 11 here – with 8% adverse events in a placebo.

The COVID-19 Inoculations - More Harm Than Good FINAL Video & Print - MoreHarm.pdf | DocDroid

https://www.docdroid.net/qQyBoKQ/the-covid-19-inoculations-more-harm-than-good-final-video-print-moreharm-pdf

The 7.7% is MORE THAN SIX TIMES higher than the 1.2% rate of more serious adverse events reported in the Pfizer clinical trial (262 serious adverse events/21,900 in the injected group in the Pfizer clinical trial).

Obviously, a person killed by the injection is not going to report to V-Safe. Indications from the clinical trial are that 456 people may have died amongst the 10 million in the V-Save survey. I cannot easily spot how long the V-Safe data survey lasted – multiply the equivalent 456 deaths by the number of six month periods of the V-Safe survey for an all-cause mortality guesstimate over the duration of the survey.

There were 20 all cause mortality deaths out of around 21,900 In the injected group in the Pfizer clinical trial within six months (a relative all cause Pfizer clinical trial all cause mortality increase of 42%!).

Back to the VaersAnalysis article:

“While the V-Safe data did not collect data on the worst adverse events that have been seen with the Covid-19 shots, it is still instructive to do a comparison of the adverse event numbers between V-Safe and VAERS for the equivalent symptoms, and then figure out how under-reported VAERS is in contrast to V-Safe. Note that for this exercise, only the adverse events in V-Safe that were classified as ‘Severe’ were counted. Had the ‘Mild’ and ‘Moderate’ categories been included, the numbers would have been roughly 7-8x higher for the 2nd column in the chart below, and the final VAERS URFs would also be an order of magnitude larger (likely in the 500-2000+ range).”